Patent · US Active

Stents modified with material comprising amnion tissue and corresponding processes

US9205177B2 · kind B2 · utility

20Cited by
46References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 26, 2010
Grant dateDec 8, 2015
Priority date
Expiry dateSep 14, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2400/18
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A stent scaffold combined with amniotic tissue provides for a biocompatible stent that has improved biocompatibility and hemocompatibility. The amnion tissue can be variously modified or unmodified form of amnion tissue such as non-cryo amnion tissue, solubilized amnion tissue, amnion tissue fabric, chemically modified amnion tissue, amnion tissue treated with radiation, amnion tissue treated with heat, or a combination thereof. Materials such as polymer, placental tissue, pericardium tissue, small intestine submucosa can be used in combination with the amnion tissue. The amnion tissue can be attached to the inside, the outside, both inside and outside, or complete encapsulation of the stent scaffold. In some embodiments, at least part of the covering or lining comprises a plurality of layers of amnion tissue. The method of making the biocompatible stent and its delivery and deployment are also discussed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.